EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evidências científicas sobre o uso de novas drogas psicodélicas no tratamento da depressão resistente

Daiane Lima De Lara Ziles, Jigliane Tainã Macedo De Souza, Yoda Janaina Ikenohuchi, Vanessa Merlen Faleiros Ferraz De Sa

Revista ft · 25.06.2026 · 30 (159) · 01-13

DOI: 10.69849/brj86f48 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista ft, online erschienen am 25.06.2026. Verfasst von Daiane Lima De Lara Ziles und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of resistant depression represents a significant challenge in psychiatry, as a considerable portion of patients do not adequately respond to conventional therapies. In this context, new psychedelic drugs have emerged as promising therapeutic alternatives, garnering increasing interest from the scientific and clinical community. The overall objective of this research is to analyze the scientific evidence regarding the efficacy and safety of using these substances in the treatment of resistant depression. To this end, a systematic literature review will be conducted, with search and critical analysis of recent scientific articles published between 2015 and 2025 in databases such as PubMed, SciELO, and Google Scholar. The methodology involves the selection of clinical studies, randomized controlled trials, and systematic reviews that address the neurobiological mechanisms, therapeutic outcomes, adverse effects, and ethical aspects involved in the use of psychedelics. It is expected that this research will contribute to the consolidation of scientific knowledge on the subject, presenting an integrated view of clinical advances and existing limitations, providing support for mental health professionals, researchers, and public policy makers. Furthermore, a critical analysis of the evidence may broaden the debate on effective alternatives for patients who do not respond to traditional treatments, in addition to promoting the destigmatization of the medicinal use of psychedelics and encouraging the adoption of evidence-based practices. Thereby, it is intended to contribute to the advancement of contemporary psychiatry, fostering the development of innovative and safe therapies that can improve the quality of life of patients with resistant depression.

Zitieren

APA

Ziles, D. L. D. L., Souza, J. T. M. D., Ikenohuchi, Y. J., & Sa, V. M. F. F. D. (2026). Evidências científicas sobre o uso de novas drogas psicodélicas no tratamento da depressão resistente. Revista ft, 30(159), 01-13. https://doi.org/10.69849/brj86f48

Vancouver

Ziles DLDL, Souza JTMD, Ikenohuchi YJ, Sa VMFFD. Evidências científicas sobre o uso de novas drogas psicodélicas no tratamento da depressão resistente. Revista ft. 2026;30(159):01-13. doi:10.69849/brj86f48

BibTeX
@article{Ziles2026,
  author = {Ziles, Daiane Lima De Lara and Souza, Jigliane Tainã Macedo De and Ikenohuchi, Yoda Janaina and Sa, Vanessa Merlen Faleiros Ferraz De},
  title = {Evidências científicas sobre o uso de novas drogas psicodélicas no tratamento da depressão resistente},
  journal = {Revista ft},
  year = {2026},
  volume = {30},
  number = {159},
  pages = {01--13},
  doi = {10.69849/brj86f48}
}
Kostenlos starten →